首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1672685

全球生技藥品市場按產品、藥物類別、給藥途徑、採購形式、分銷管道和地區分類

Biologics Market, By Product, By Drug Classification, By Route of Administration, By Mode of Purchase, By Distribution Channel,By Geography

出版日期: 2025年02月07日 | 出版商:

Coherent Market Insights | 英文 210 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球生技藥品市場規模估計為 5.775 億美元，預計到 2032 年將達到 11.698 億美元，2025 年至 2032 年的複合年成長率為 10.6%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	5.775億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	10.60％	2032 年價值預測	11.698億美元

市場佔有率。

生技藥品是由生物體製成的藥物，用於預防、治療或治癒人類疾病。其中包括疫苗、血液成分、過敏原、體細胞、基因療法、組織和重組治療性蛋白質。全球慢性病盛行率不斷上升，加上易患各種疾病的老年人口不斷增加，可能會增加對生技藥品的需求。生物技術的快速創新和進步使得開發安全性、有效性和作用特異性更高的新型生物製藥成為可能。這擴大了多種危及生命的疾病的治療選擇，包括癌症、風濕病和自體免疫疾病。擴大監管核准和生技藥品商業化可能會推動市場成長。

市場動態

全球生技藥品市場的成長得益於糖尿病、癌症和心血管疾病等慢性病在全球的盛行率不斷上升，以及醫療保健對生技藥品研發支出的不斷增加。此外，對蛋白質類藥物的需求不斷增加、先進生技藥品的快速核准以及強勁的新型生技藥品候選產品線也在推動市場成長。生物加工和品質分析技術的不斷進步，促進了高產生產平台的開發，有利於商業規模上經濟高效地生產生技藥品。然而，建立生物製造設施所需的大量資本投入、嚴格的監管標準以及生物分子的複雜性對開發生物相似藥構成了挑戰。亞太和拉丁美洲等新興市場為相關人員探索新市場和抵銷市場限制提供了有利可圖的機會。

本研究的主要特點

本報告對全球生技藥品市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032 年）的市場規模和複合年成長率。

它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球生技藥品市場的主要企業已根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行了分析。

研究涉及的主要企業包括 F. Hoffmann-La Roche、AbbVie、安進、強生服務公司、默克、輝瑞、賽諾菲、吉利德科學、諾華、百時美施貴寶、再生元、武田工業、百健、禮來公司和 Celltrion Healthcare。

本報告的見解可以幫助負責人和企業經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。

全球生技藥品市場報告迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過分析全球生技藥品市場所使用的各種策略矩陣更輕鬆地做出決策。

Hoffmann-La Roche Ltd.
AbbVie Inc.
Amgen Inc.
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Pfizer Inc.
Sanofi SA
Gilead Sciences, Inc.
Novartis AG
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Eli Lilly and Company
Celltrion Healthcare Co., Ltd.

第 11 章參考文獻與調查方法

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI2663

Global Biologics Market is estimated to be valued at USD 577.5 Mn in 2025 and is expected to reach USD 1,169.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 10.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 577.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	10.60%	2032 Value Projection:	USD 1,169.8 Mn

Figure. Biologics Market Share (%), By Region 2025

Biologics refers to medicines created from living organisms that are used to prevent, treat, and cure human diseases. These include vaccines, blood components, allergenics, somatic cells, gene therapies, tissues, and recombinant therapeutic proteins. Increasing prevalence of chronic diseases worldwide coupled with rising elderly population prone to various illnesses can boost demand for biologics. Rapid innovations and advancements in biotechnology have enabled development of novel biologic agents with improved safety, efficacy and specificity of action. This has expanded treatment options for several life-threatening conditions such as cancer, rheumatic disorders, and autoimmune diseases. Growing regulatory approvals and commercialization of biologics can drive the market growth.

Market Dynamics

Global biologics market growth is driven by growing prevalence of chronic diseases worldwide such as diabetes, cancer, cardiovascular diseases along with rising healthcare expenditure on biopharmaceutical R&D. Increasing demand for protein-based drugs, rapid approvals of advanced biologics and strong pipeline of novel biologic candidates can also drive the market growth. Constant technological advancements in bioprocessing and quality analytics enables development of high-yield production platforms conducive for cost-effective manufacturing of biologics at commercial scale. However, factors such as high capital investment needs for setting up bio-manufacturing facilities, stringent regulatory norms, and complexity of biological molecules poses challenges in biosimilar development. Emerging markets across developing regions such as Asia Pacific and Latin America offer lucrative opportunities for stakeholders to tap into new geographic territories and offset restraint impact.

Key Features of the Study

This report provides in-depth analysis of the global biologics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global biologics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., AbbVie Inc., Amgen Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sanofi S.A., Gilead Sciences, Inc., Novartis AG, Bristol-Myers Squibb Company, Regeneron Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Eli Lilly and Company, and Celltrion Healthcare Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global biologics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biologics market

Market Segmentation

By Product Insights (Revenue, USD Mn, 2019 - 2032)
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cellular-based Biologics
- Gene-based Biologics
- Others
By Drug Classification Insights (Revenue, USD Mn, 2019 - 2032)
- Branded Drugs
- Generic Drugs
By Route of Administration Insights (Revenue, USD Mn, 2019 - 2032)
- Oral
- Parenteral
- Other Routes
By Mode of Purchase Insights (Revenue, USD Mn, 2019 - 2032)
- Prescription-Based Drugs
- Over-The-Counter Drugs
By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2019 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- F. Hoffmann-La Roche Ltd.
- AbbVie Inc.
- Amgen Inc.
- Johnson & Johnson Services, Inc.
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi S.A.
- Gilead Sciences, Inc.
- Novartis AG
- Bristol-Myers Squibb Company
- Regeneron Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Biogen Inc.
- Eli Lilly and Company
- Celltrion Healthcare Co., Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Biologics Market, By Product
- Global Biologics Market, By Drug Classification
- Global Biologics Market, By Route of Administration
- Global Biologics Market, By Mode of Purchase
- Global Biologics Market, By Distribution Channel
- Global Biologics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
- Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Biologics Market, By Product, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Recombinant Hormones/Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Cellular-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Gene-based Biologics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Biologics Market, By Drug Classification, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Branded Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Generic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Biologics Market, By Route of Administration, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Other Routes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Biologics Market, By Mode of Purchase, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Prescription-Based Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Over-The-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Biologics Market, By Distribution Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Biologics Market, By Region, 2020 - 2032, (USD Mn)

Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Drug Classification, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Mode of Purchase, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Hoffmann-La Roche Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson Services, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi S.A.
Gilead Sciences, Inc.
Novartis AG
Bristol-Myers Squibb Company
Regeneron Pharmaceuticals, Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Eli Lilly and Company
Celltrion Healthcare Co., Ltd.